H. Kauczor (Heidelberg, Germany), I. Opitz (Zurich, Switzerland), T. Blum (Berlin, Germany)
to describe modern diagnostic and therapeutic approaches that can substantially improve the prognosis of lung cancer patients; to enable participants close interaction with the multidisciplinary faculty from leading international societies in the field of lung cancer and by that learn how to deliver best care to lung cancer patients.
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care D. Arenberg (Ann Arbor, United States of America)
| |
Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives T. Blum (Berlin, Germany)
| |
How (molecular) pathologists can profile patients S. Stephan-Falkenau (Berlin, Germany)
| |
New insights into lung cancer: what radiologists can contribute to diagnosis and staging A. Snoeckx (Edegem (Antwerp), Belgium)
| |
Group assignment T. Blum (Berlin, Germany), D. Arenberg (Ann Arbor, United States of America), S. Stephan-Falkenau (Berlin, Germany), A. Snoeckx (Edegem (Antwerp), Belgium)
| |
Modern staging in lung cancer: from the current multidisciplinary process to novel approaches M. Paats (Rotterdam, Netherlands)
| |
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the thoracic surgeon N. Novoa Valentin (Salamanca, Spain)
| |
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the radiotherapist D. De Ruysscher (Maastricht, Netherlands)
| |
Early, locally advanced and metastasised NSCLC: core strategies from the perspective of the (pneumo) oncologist P. Tomasini (Marseille, France)
| |
Group assignment P. Tomasini (Marseille, France), N. Novoa Valentin (Salamanca, Spain), D. De Ruysscher (Maastricht, Netherlands), M. Paats (Rotterdam, Netherlands)
| |